LICORbio Cell & Gene Tech Expo April 2026: Cell Therapy

Jessica Zinskie, PhD, will explore how the In-Cell Western™ Assay and Odyssey® Imaging Systems can be leveraged to perform quantitative, high-throughput potency assays to support cell and gene therapy development. Attendees will gain insights into regulatory considerations, assay validation strategies, real-world case studies, and head-to-head comparisons with traditional methods such as Western blot, ELISA, flow cytometry, and microscopy.

About LICORbio

Throughout its 30+ year history, LICORbio has developed revolutionary quantitative fluorescence imaging technologies to address the growing needs of the global scientific community. With over 120,000 citations in peer-reviewed publications, scientists trust LICORbio to be their constant partner despite the unpredictability of research. LICORbio offers complete, integrated solutions for quantitative protein research, immunocytochemistry, and 2D and 3D cell culture imaging. The LICORbio Atlas™ Imaging System simplifies workflows, eliminates inefficiencies, and quantifies deep spatial insights in New Approach Methodologies (NAMs) such as organoids, spheroids, tumoroids, and microphysiological system imaging for drug development and translational research.

From innovative protocols and industry-leading imaging systems to powerful analysis software, affordable reagents, and world-class scientific support, LICORbio empowers researchers around the world to answer difficult questions, make groundbreaking discoveries, and improve countless facets of human health. LICORbio is ISO 9001:2008 certified and provides 21 CFR Part 11-ready software.